MedPath

Dysfunctional Hemoglobin

Completed
Conditions
Elevated Levels of Carboxyhemoglobin and Methemoglobin
Interventions
Other: Elevated levels of carboxyhemoglobin
Registration Number
NCT02262195
Lead Sponsor
Nonin Medical, Inc
Brief Summary

The purpose of the study is to determine if a new pulse oximeter accurately detects carboxyhemoglobin and methemoglobin when intentionally increased in the blood.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Subjects does not have significant medical problems
  • Subject is willing to provide written informed consent
  • Subject is between 18 and 45 years of age
Exclusion Criteria
  • Has a BMI greater than 31
  • Has had any relevant injury at the sensor location site
  • Has deformities or abnormalities that may prevent proper application of the device under test
  • Has a known respiratory condition
  • Is currently a smoker
  • Has a known heart or cardiovascular condition
  • Is currently pregnant
  • Is female and actively trying to get pregnant
  • Has a clotting disorder
  • Is known to have a hemoglobinopathy such as (anemia, bilirubinemia, sickle-cell anemia, inherited or congenital methemoglobinemia)
  • The subject has a COHb greater than 3% or MetHb greater than 2%
  • Has taken blood thinners or medication with aspirin within the last 24 hours
  • Has unacceptable collateral circulation from the ulnar artery
  • Has donated more than 300 mL of blood within one month prior to start of study
  • Is unwilling or unable to provide written informed consent to participate in the study
  • Is unwilling or unable to comply with the study procedures
  • Has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CarboxyhemoglobinElevated levels of carboxyhemoglobinInduced carboxyhemoglobin levels up tp 15 percent.
MethemoglobinElevated levels of carboxyhemoglobinInduced methemoglobin levels up to 15 percent.
Primary Outcome Measures
NameTimeMethod
Evaluate carboxyhemoglobin over the range of 0-15 percent as assessed by co-oximetry4 hours
Evaluate methemoglobin over the range of 0-15 percent as assessed by co-oximetry4 hours
Secondary Outcome Measures
NameTimeMethod
Determine oxygen saturation accuracy in conditions of elevated methemoglobin4 hours
Determine oxygen saturation accuracy in conditions of elevated carboxyhemoglobin4 hours

Trial Locations

Locations (1)

University of California San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath